Dr. Renkens has been involved in the development and commercial success of medical devices used in operating rooms around the world, Medcura said in an April 26 announcement of his appointment. He specialized in neck and back conditions before retiring from his clinical practice last year.
Medcura develops hemostatic products for surgical, medical and consumer use.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
